|
Stroke death rate no lower with NovoSeven therapy
Reuters - By Gene Emery BOSTON, May 14 (Reuters) - A hemophilia drug made by Novo Nordisk (NOVOb.CO: Quote, Profile, Research) did not save the lives of patients … |
More: continued here
If you like this post, please buy me a beer for $3 8-)
Blogsphere: TechnoratiFeedsterBloglines
Bookmark: Del.icio.usSpurlFurlSimpyBlinkDigg
RSS feed for comments on this post | TrackBack URI for this post


















